Atrial Fibrillation in Canine Dilated Cardiomyopathy: Why Early ECG Intervention Can Change the Outcome

Arrhythmias in dogs with dilated cardiomyopathy (DCM) can rapidly transform a compensated cardiac patient into a critical one. Among the various rhythm disturbances associated with DCM, atrial fibrillation remains one of the most clinically significant because of its direct impact on ventricular filling, cardiac output, and progression of congestive heart failure^1,2. 

In many dogs, the first warning sign is not severe respiratory distress or collapse, but an irregularly irregular rhythm detected during routine cardiac auscultation. This makes electrocardiographic evaluation an essential part of every suspected DCM workup¹. 

A clinical evaluation involving 52 dogs with DCM highlighted how frequently ECG abnormalities accompany myocardial disease. Dogs commonly presented with dyspnea, cough, ascites, limb edema, murmurs, gallop rhythms, and arrhythmias on auscultation. Labrador Retrievers represented the majority of affected cases, although Dobermans, Rottweilers, German Shepherds, Golden Retrievers, Beagles, Pugs, and non-descript breeds were also included¹. 

When the ECG Reveals More Than Tachycardia 

Sinus tachycardia was the most commonly observed ECG abnormality, but atrial fibrillation emerged as the most clinically important arrhythmia. Electrocardiographic findings included¹: 

• Absence of organized P waves  

• Irregular R-R intervals  

• Rapid ventricular response  

In dogs with DCM, atrial fibrillation significantly compromises ventricular filling because coordinated atrial contraction is lost. In an already weakened myocardium, this additional hemodynamic burden can worsen exercise intolerance, respiratory distress, and circulatory instability. 

Clinically, affected dogs frequently demonstrate¹: 

• Rapid irregular heart rhythm  

• Pulse deficits  

• Weak and varying pulse quality  

• Reduced exercise tolerance  

• Progressive fatigue  

Presence of atrial fibrillation is also considered an important negative prognostic indicator in canine DCM, making early recognition particularly important^1,3. 

Why Rate Control Matters More Than Rhythm Conversion 

Management of atrial fibrillation in dogs with DCM often focuses initially on controlling ventricular rate rather than aggressively pursuing rhythm conversion. 

Affected dogs were treated using: 

• Diltiazem @ 1–1.5 mg/kg TID  

• Digoxin @ 0.003 mg/kg BID orally  

Diltiazem functions as a calcium channel blocker and class IV antiarrhythmic agent that slows atrioventricular conduction, while digoxin contributes through sympathetic inhibition and parasympathomimetic effects¹. 

The combination creates a stronger negative chronotropic effect compared with either drug used individually⁴. Clinically, this translates into improved ventricular rate control and better cardiovascular stability. 

Interestingly, follow-up ECG monitoring demonstrated that while some dogs reverted to sinus rhythm, others continued with controlled atrial fibrillation despite significant clinical improvement. This highlights an important practical point for veterinarians, successful management does not always require complete rhythm conversion. 

Ventricular Arrhythmias Can Complicate the Picture 

Electrocardiographic monitoring also identified ventricular premature complexes (VPCs) in several dogs, including one case of ventricular bigeminy. These arrhythmias originate from ectopic ventricular pacemakers and indicate myocardial electrical instability¹. 

Sotalol therapy was used successfully for the management of ventricular ectopy. As a selective beta-blocker with class III antiarrhythmic activity, sotalol demonstrated effective suppression of ventricular premature complexes during follow-up monitoring¹. 

Because ventricular arrhythmias may predispose dogs to sudden deterioration, continuous ECG monitoring remains clinically valuable even after atrial fibrillation has been identified. 

Additional ECG Findings with Clinical Relevance 

Apart from arrhythmias, several dogs demonstrated ST-segment coving suggestive of myocardial hypoxia or subendocardial ischemia¹. Reduced cardiac output, combined with persistent tachycardia, likely contributed to these changes. 

Low-amplitude QRS complexes were also observed in dogs with pleural or pericardial effusion secondary to congestive heart failure. 

These findings reinforce the importance of interpreting ECG abnormalities alongside echocardiographic findings, thoracic imaging, and overall clinical presentation. 

Clinical Takeaway 

Dogs with DCM rarely suffer from structural cardiac disease alone. Electrical instability frequently determines disease severity, treatment response, and long-term outcome. 

Careful ECG evaluation allows early identification of arrhythmias, guides antiarrhythmic therapy, and helps clinicians monitor progression more effectively. In many canine DCM patients, timely ventricular rate control may substantially improve quality of life even when atrial fibrillation persists. 

References 

1. Saikrishna KS, Jeyaraja K, Vairamuthu S, Shafiuzama M, Selvaraj P. Electrocardiographic abnormalities in canine dilated cardiomyopathy and their management. https://krishikosh.egranth.ac.in/server/api/core/bitstreams/cec902a6-ec35-4ad4-a0dc-f2eaaf0f969f/content 

2. Pedro B, Fontes-Sousa AP, Gelzer AR. Canine atrial fibrillation: Pathophysiology, epidemiology and classification. The Veterinary Journal. 2020 Nov 1;265:105548. https://doi.org/10.1016/j.tvjl.2020.105548 

3. Friederich J, Seuß AC, Wess G. The role of atrial fibrillation as a prognostic factor in doberman pinschers with dilated cardiomyopathy and congestive heart failure. The Veterinary Journal. 2020 Oct 1;264:105535. https://doi.org/10.1016/j.tvjl.2020.105535 

4. Gelzer AR, Kraus MS, Rishniw M, Moïse NS, Pariaut R, Jesty SA, Hemsley SA. Combination therapy with digoxin and diltiazem controls ventricular rate in chronic atrial fibrillation in dogs better than digoxin or diltiazem monotherapy: a randomized crossover study in 18 dogs. Journal of veterinary internal medicine. 2009 May;23(3):499-508. https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1939-1676.2009.0301.x